Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis

To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin's lymphoma (HL). 39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis. The median age at diagnosis of HL and BC was 25.3 a...

Full description

Saved in:
Bibliographic Details
Published in:Radiation oncology (London, England) England), 2009-06, Vol.4 (1), p.19-19, Article 19
Main Authors: Alm El-Din, Mohamed A, Hughes, Kevin S, Raad, Rita A, Goldberg, Saveli I, Aisenberg, Alan C, Niemierko, Andrzej, Taghian, Alphonse G
Format: Article
Language:English
Subjects:
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Breast cancer
Breast Neoplasms - etiology
Care and treatment
Case-Control Studies
Child
Combined Modality Therapy
Diagnosis
Female
Health aspects
Hodgkin Disease - drug therapy
Hodgkin Disease - radiotherapy
Hodgkin's disease
Humans
Mammography
Middle Aged
Neoplasm Staging
Neoplasms, Radiation-Induced - etiology
Neoplasms, Second Primary - etiology
Prognosis
Radiotherapy
Retrospective Studies
Risk Factors
Survival Rate
Treatment Outcome
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate diagnosis, management and outcome of breast cancer (BC) occurring after irradiation for Hodgkin's lymphoma (HL). 39 cases of BC in 28 HL survivors were retrospectively reviewed. 21 patients were included in a case-control analysis. The median age at diagnosis of HL and BC was 25.3 and 45.3 years, respectively. The median interval to develop BC was 16.1 years. Eleven women (39.2%) had bilateral disease. Mode of detection of the index breast cancers was by mammographic screening in 17 patients (60.7%), palpable lump in 8 patients (28.6%), clinical examination in two patients (7.1%), and unknown in one patient (3.6%). Case-control analysis showed that histological features and prognosis of BC after HL were similar to those of primary BC, however, for BC after HL, mastectomy was the predominant surgery (P = .001) and adjuvant radiotherapy and anthracycline-based chemotherapy were less frequently used as compared to primary BC (P < .001 and .003, respectively). The previous history of HL does not appear to be a poor prognostic factor for BC occurring thereafter.
ISSN:1748-717X
1748-717X
DOI:10.1186/1748-717X-4-19